Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Immunology ; 103(1): 98-105, 2001 May.
Article in English | MEDLINE | ID: mdl-11380697

ABSTRACT

In the present study, the adjuvant effect of zymosan on human immunodeficiency virus type-1 (HIV-1)-specific DNA vaccine and the mechanism of this enhancement were studied in a murine model. We coinoculated zymosan with our candidate HIV-1 specific DNA vaccine (pCMV160IIIB) into skeletal muscles of BALB/c mice. Higher levels of both humoral immune response and HIV-specific delayed-type hypersensitivity (DTH) response were observed when zymosan was coinoculated with pCMV160IIIB compared with that obtained using pCMV160IIIB alone. HIV-specific cytotoxic T lymphocyte (CTL) activity was also enhanced. This enhancing activity was suppressed when coinoculated to the fifth complement (C5)-deficient DDD and AKR mice. The enhanced activity was also suppressed when anti-C3 antibody was inoculated to mice intramuscularly. There was significant induction of immunoglobulin G2a (IgG2a) and interferon-gamma (IFN-gamma) in pCMV160IIIB vaccine with zymosan. These results suggest that zymosan-mediated DNA vaccination enhances helper T cell (Th) 1-mediated immunity. The effect is suggested to be based on the consequences of its recruitment and activation of macrophages, dendritic cells or antigen-presenting cells (APC) through complement activation, especially through the alternative pathway. Taken together, these results suggest that zymosan can be an effective immunological adjuvant in DNA vaccination against HIV-1.


Subject(s)
AIDS Vaccines/immunology , Adjuvants, Immunologic , HIV-1/immunology , Vaccines, DNA/immunology , Zymosan/immunology , Animals , Complement Activation/immunology , Cytokines/biosynthesis , Female , HIV Antibodies/biosynthesis , Immunity, Cellular , Immunization , Immunoglobulin G/biosynthesis , Mice , Mice, Inbred AKR , Mice, Inbred BALB C , Muscle, Skeletal/immunology , T-Lymphocytes, Cytotoxic/immunology
2.
Int Orthop ; 24(6): 327-30, 2001.
Article in English | MEDLINE | ID: mdl-11294423

ABSTRACT

We reviewed 11 knees in ten patients at a mean follow-up of 23 years after a modified Loeffler's medial capsulotomy for osteoarthritis of the knee. The mean age was 59+/-8 years at surgery. The mean knee score (Hospital for Special Surgery) was 59 points before surgery and 79 points at follow-up. The long-term results of this operation were thus maintained over a prolonged period. This is a relatively simple procedure, which may be performed in the elderly, with satisfactory long-term results.


Subject(s)
Osteoarthritis, Knee/surgery , Adult , Aged , Female , Follow-Up Studies , Humans , Male , Middle Aged , Orthopedic Procedures , Osteoarthritis, Knee/diagnostic imaging , Radiography , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...